(甲氧基甲氧基甲基)三丁基锡 | 100045-83-8

• 分子结构分类: 有机化合物 - 有机金属化合物 - 有机过渡后金属化合物
• 中文名称: (甲氧基甲氧基甲基)三丁基锡
• 英文名称: tributyl({[(methyloxy)methyl]oxy}methyl)stannane
• 英文别名: tributyl((methoxymethoxy)methyl)stannane；(methoxymethoxymethyl)-tri-n-butylstannane
• CAS: 100045-83-8
• 化学式: C₁₅H₃₄O₂Sn
• 分子量: 365.144
• InChiKey: MHKKJWZUBFCJSI-UHFFFAOYSA-N

物化性质

• 沸点：
  84-87 °C(Press: 0.05 Torr)
• 溶解度：
  溶于氯仿、二氯甲烷、乙酸乙酯、甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  5.0
• 重原子数：
  18
• 可旋转键数：
  13
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• WGK Germany：
  3
• 储存条件：
  2~8℃

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : Tributyl[(methoxymethoxy)methyl]stannane
Index-No. : 050-008-00-3
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 100045-83-8
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 3), H301
Acute toxicity, Dermal (Category 4), H312
Skin irritation (Category 2), H315
Eye irritation (Category 2), H319
Specific target organ toxicity - repeated exposure (Category 1), H372
Acute aquatic toxicity (Category 1), H400
Chronic aquatic toxicity (Category 1), H410
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
T Toxic R25, R48/23/25
Xn Harmful R21
Xi Irritant R36/38
N Dangerous for the R50/53
environment
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Danger
Hazard statement(s)
H301 Toxic if swallowed.
H312 Harmful in contact with skin.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H372 Causes damage to organs through prolonged or repeated exposure.
H410 Very toxic to aquatic life with long lasting effects.
Precautionary statement(s)
P273 Avoid release to the environment.
P280 Wear protective gloves/ protective clothing.
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/
physician.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P314 Get medical advice/ attention if you feel unwell.
P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental Hazard none
Statements
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Substances
Formula : C15H34O2Sn
Molecular Weight : 365,14 g/mol
CAS-No. : 100045-83-8
Index-No. : 050-008-00-3
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
Tributyl[(methoxymethoxy)methyl]stannane
CAS-No. 100045-83-8 Acute Tox. 3; Acute Tox. 4; <= 100 %
Index-No. 050-008-00-3 Skin Irrit. 2; Eye Irrit. 2; STOT
RE 1; Aquatic Acute 1; Aquatic
Chronic 1; H301, H312, H315,
H319, H372, H410
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
Tributyl[(methoxymethoxy)methyl]stannane
CAS-No. 100045-83-8 T, N, R21 - R25 - R36/38 - <= 100 %
Index-No. 050-008-00-3 R48/23/25 - R50/53
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Tin/tin oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling
the product.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
respirator type N99 (US) or type P2 (EN 143) respirator cartridges as a backup to engineering
controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
respirators and components tested and approved under appropriate government standards such
as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into
the environment must be avoided.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents, Strong acids, Strong bases
Hazardous decomposition products
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
Irritating to skin.
Serious eye damage/eye irritation
Eye irritation
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
Causes damage to organs through prolonged or repeated exposure.
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
Very toxic to aquatic life with long lasting effects.
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: 3146 IMDG: 3146 IATA: 3146
UN proper shipping name
ADR/RID: ORGANOTIN COMPOUND, SOLID, N.O.S. (Tributyl[(methoxymethoxy)methyl]stannane)
IMDG: ORGANOTIN COMPOUND, SOLID, N.O.S. (Tributyl[(methoxymethoxy)methyl]stannane)
IATA: Organotin compound, solid, n.o.s. (Tributyl[(methoxymethoxy)methyl]stannane)
Transport hazard class(es)
ADR/RID: 6.1 IMDG: 6.1 IATA: 6.1
Packaging group
ADR/RID: II IMDG: II IATA: II
Environmental hazards
ADR/RID: no IMDG Marine pollutant: yes IATA: no
Special precautions for user
no data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

---

SECTION 16: Other information
Full text of H-Statements referred to under sections 2 and 3.
Acute Tox. Acute toxicity
Aquatic Acute Acute aquatic toxicity
Aquatic Chronic Chronic aquatic toxicity
Eye Irrit. Eye irritation
H301 Toxic if swallowed.
H312 Harmful in contact with skin.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H372 Causes damage to organs through prolonged or repeated exposure.
H400 Very toxic to aquatic life.
H410 Very toxic to aquatic life with long lasting effects.
Full text of R-phrases referred to under sections 2 and 3
N Dangerous for the environment
T Toxic
R21 Harmful in contact with skin.
R25 Toxic if swallowed.
R36/38 Irritating to eyes and skin.
R48/23/25 Toxic: danger of serious damage to health by prolonged exposure through inhalation
and if swallowed.
R50/53 Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic
environment.
Further information
Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  (甲氧基甲氧基甲基)三丁基锡 在 正丁基锂 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 0.5h， 生成 (methoxymethoxy)methyllithium
  参考文献：
  名称：

  霉酚酸的全合成

  摘要：

  这些合成 a partir de t-丁基二甲基甲硅烷氧基-8 (=R-8) 甲氧基-1 甲基-5 辛烯-4yne-1 和去甲氧基甲氧基甲基-3 (=R'-3) 甲基-2 环丁烯-2one-1 通过环化 de l' 酸 R-3 R'-6 羟基-2 甲氧基-4 甲基-5 苯甲酸

  DOI：

  10.1021/ja00264a038
• 作为产物：
  描述：

  三正丁基氢锡 在 正丁基锂 、 三氟化硼乙醚 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 为溶剂， 反应 23.5h， 生成 (甲氧基甲氧基甲基)三丁基锡
  参考文献：
  名称：

  用作天然光合氢卟啉前体的手性己炔酮的合成

  摘要：

  光合四吡咯大环化合物的计划全合成通过已建立的不对称方法在早期前体中安装了必要的立体化学特征。关键构建模块是含有手性吡咯啉单元的二氢二吡啶，手性六-5-yn-2-酮是其有价值的前体。寻找在 1 位带有不同官能团的手性 hex-5-yn-2-one，其对应于细菌叶绿素 a 的手性吡咯啉单元（环 B 和 D ）。本文报告了三个主要结果。首先，将通过Schreiber 改进的尼古拉斯反应制备的 (2 R ,3 R )-3-乙基-2-甲基戊-4-炔酸转化为类似的手性 Weinreb 戊酰胺。后者用三丁基锡-一碳合成子处理，产生 1-羟基己基-5-yn-2-酮支架，其中包含两个必需的立体中心，并具有新引入的游离形式或保护为 Me、MOM、THP 的羟基。 、MEM、Bn 或 SEM 导数。其次，在获得前 B 化合物 (3 R ,4 R )-1,1-二甲氧基-3-乙基-4-甲基己-5-yn-2-one

  DOI：

  10.1039/d3nj03900e

文献信息

• Heterocyclic Compounds as MEK Inhibitors
  申请人：Chikkanna Dinesh

  公开号：US20090275606A1

  公开（公告）日：2009-11-05

  The present invention relates to compounds of formula I and pharmaceutically acceptable salts. These compounds can act as potential MEK inhibitors in the treatment of hyperproliferative diseases, like cancer and inflammation. The present invention also reveals methods of preparation thereof.

  本发明涉及公式I的化合物和药用盐。这些化合物可以作为潜在的MEK抑制剂，用于治疗癌症和炎症等过度增殖性疾病。本发明还揭示了其制备方法。
• Total Synthesis of (−)‐Tetrodotoxin and 11‐norTTX‐6( <i>R</i> )‐ol
  作者：Tomoaki Maehara、Keisuke Motoyama、Tatsuya Toma、Satoshi Yokoshima、Tohru Fukuyama

  DOI：10.1002/anie.201611574

  日期：2017.2

  The enantioselective total synthesis of (−)‐tetrodotoxin [(−)‐TTX] and 4,9‐anhydrotetrodotoxin, which are selective blockers of voltage‐gated sodium channels, was accomplished from the commercially available p‐benzoquinone. This synthesis was based on efficient stereocontrol of the six contiguous stereogenic centers on the core cyclohexane ring through Ogasawara's method, [3,3]‐sigmatropic rearrangement

  对映体选择性合成（-）-河豚毒素[（-）-TTX]和4,9-脱水河豚毒素，它们是电压门控钠通道的选择性阻滞剂，是通过市售的对-苯醌完成的。该合成是基于通过Ogasawara方法对核心环己烷环上六个连续的立体异构中心进行有效的立体控制，烯丙基氰酸酯的[3,3]-σ重排以及一氧化氮的分子内1,3-偶极环加成。我们的合成路线施加到河豚毒素同源的合成11-norTTX-6（[R ）-醇和4,9-脱水-11- norTTX-6（ř）-对通用中间体进行后期修改。最后一步的中性脱保护使得河豚毒素和11-norTTX-6（R）-ol易于纯化，而不会竞争脱水成4,9-脱水形式。
• [EN] N- CYCLOBUTYL - IMIDAZOPYRIDINE - METHYLAMINE AS TRPV1 ANTAGONISTS<br/>[FR] N-CYCLOBUTYL-IMIDAZOPYRIDINE-MÉTHYLAMINE À TITRE D'ANTAGONISTE DES TRPV1
  申请人：GLAXO GROUP LTD

  公开号：WO2012139963A1

  公开（公告）日：2012-10-18

  A compound of formula (I) wherein X represents a H atom, or a CH2OH group, Y represents a H atom, or a CH2OH group, but X and Y are not both CH2OH groups and Ar is selected from formulae (IA) and (IB) or a pharmaceutically acceptable salt thereof, useful as TRPY1(VR-1) antagonists.

  式（I）的化合物，其中X代表H原子或CH2OH基团，Y代表H原子或CH2OH基团，但X和Y不都是CH2OH基团，Ar选自式（IA）和（IB）或其药学上可接受的盐，用作TRPY1（VR-1）拮抗剂。
• Chemoenzymatic Synthesis of Advanced Intermediates for Formal Total Syntheses of Tetrodotoxin
  作者：Daler Baidilov、Lukas Rycek、John F. Trant、Jordan Froese、Brennan Murphy、Tomas Hudlicky

  DOI：10.1002/anie.201804602

  日期：2018.8.20

  Advanced intermediates for the syntheses of tetrodotoxin reported by the groups of Fukuyama, Alonso, and Sato were prepared. Key steps include the toluene dioxygenase mediated dihydroxylation of either iodobenzene or benzyl acetate. The resulting diene diols were transformed into Fukuyama's intermediate in six steps, into Alonso's intermediate in nine steps, and into Sato's intermediate in ten steps

  制备了由福山，阿隆索和佐藤小组报告的河豚毒素合成的高级中间体。关键步骤包括碘代苯或乙酸苄酯的甲苯双加氧酶介导的二羟基化。所得的二烯二醇经六步转化为福山中间体，经九步转化为阿隆索的中间体，并经十步转化为佐藤的中间体。
• The Naturally Occurring Ketene Acetal Benesudon: Total Synthesis and Assignment of Relative and Absolute Stereochemistry
  作者：Derrick L. J. Clive、Minaruzzaman、Haikang Yang

  DOI：10.1021/jo801028y

  日期：2008.9.1

  the five-membered ring, and oxidative decarboxylation to generate the key central double bond. The originally suggested stereochemistry for the quaternary center C(5) must be revised, as both C(5) epimers were prepared and a comparison with an authentic sample was made. The absolute configuration of benesudon is 4S,5R,6S.

  由D-葡萄糖通过涉及自由基环化形成五元环，氧化脱羧以生成关键的中央双键的途径，由D-葡萄糖合成了具有生物活性的真菌代谢物即致密功能化的乙烯酮乙缩醛苄酮。由于两个C（5）差向异构体均已制备，并且与真实样品进行了比较，因此必须修改最初建议的四元中心C（5）的立体化学。贝尼松糖的绝对构型为4S，5R，6S。